US 10526656
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted A61KA61K31/44A61P
Quick answer
US patent 10526656 (Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers) held by Transgenion—International Institute for Regenerative Translational Medicine GmbH expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Transgenion—International Institute for Regenerative Translational Medicine GmbH
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/44, A61P, A61P11/00